Contents:

1. Analyst View 2. Global Generic Drugs Market 3. US Generic Drugs Market 3.1 Pharmaceutical Market 3.1.1 Branded Drugs 3.1.2 Generic Drugs 4. Regulatory Environment 4.1 Drug Efficacy Study Implementation (DESI) Program 4.2 Hatch-Waxman Act 4.3 Patent Infringement Litigations 4.4 Para IV & the 180-day Marketing Exclusivity 4.5 FDA Requirements 4.6 Generic Initiative for Value & Efficiency (GIVE) 5. Emerging Market Trends 5.1 Patent Expiries of Key Drugs 5.2 Huge Cost Savings 5.3 Biogenerics 5.4 Contract Manufacturing 5.5 Drugs Packaging 5.6 Drugs Delivery 5.7 Favorable Political Environment 5.8 Ageing Population 6. Growth Inhibitors 6.1 Lawsuits 6.2 Entry Barriers 6.3 Price Erosion and Depleting Margins 6.4 Authorized Generics 7. Competitive Landscape 7.1 Market Share of Key Players 7.2 Profile of Key Players 7.2.1 Teva Pharmaceutical Industries Limited 7.2.2 Watson Pharmaceuticals, Inc. 7.2.3 Mylan Laboratories Inc. 7.2.4 Sandoz Inc. 7.2.5 Pfizer 8. Supporting Databases 8.1 Macroeconomic Indicators 8.2 Population 8.3 Demographics 8.4 Healthcare Expenditure 8.5 Healthcare Infrastructure 8.6 Major Causes of Mortality List of Tables: Table 3-1: Top Therapeutic Categories by Sales (Billion US$), 2008 Table 5-1: Blockbuster Drugs Going Off-patent Globally (2010 to 2012) Table 5-2: Patent Expiry Dates for Biopharmaceuticals Table 7-1: Top 10 Players by Sales in Pharmaceutical Market (Billion US$), 2008 Table 7-2: Top 10 Players by Prescriptions Dispensed in Generic Drugs Market (Million), 2008 Table 8-1: Number of Deaths due to Leading Causes (2006) List of Figures: Figure 2-1: Global - Wine Consumption (Billion Liter), 2004-2008 Figure 2-2: Global - Wine Consumption by Country (%), 2008 Figure 3-1: Global - Wine Production by Region (%), 2008 Figure 3-2: Global - Wine Production by Country (%), 2008 Figure 3-3: US - Share in Global Wine Consumption (2008) Figure 3-4: Global - Wine Imports by Country (%), 2007 Figure 3-5: Global - Wine Exports by Country (%), 2008 Figure 4-1: Relative Risk of Death with Frequency of Wine Consumption Figure 4-2: Reduction in Salmonella based Food Poisoning on Wine Consumption (Units/ml) Figure 4-3: US - Per Capita Wine Consumption (Gallons), 2004-2008 Figure 4-4: US - Wine Consumption Frequency (%), 2006 & 2008 Figure 4-5: US - Core and Marginal Wine Consumer by Gender (%), 2008 Figure 4-6: US - Net Percent Gain/Loss in Wine Consumption by Generation (2008) Figure 5-1: US - Wine Production (Million Gallons), 2004-2008 Figure 5-2: US - Number of Wineries (2005-2008) Figure 5-3: US - Total Wine Sales (Million Gallons), 2004-2008 Figure 5-4: US - Total Wine Sales (Billion US$), 2004-2008 Figure 5-5: US - Wine Sales by Price Segment (%), 2008 & 2009 Figure 5-6: US - Forecast for Wine Sales (Million Gallons), 2009-2012 Figure 5-7: US - Forecast for Wine Sales (Billion US$), 2009-2012 Figure 5-8: US - Total Wine Sales by Product (%), 2008 Figure 5-9: US - Table Wine Sales (Million Gallons), 2004-2008 Figure 5-10: US - Forecast for Table Wine Sales (Million Gallons), 2009-2012 Figure 5-11: US - Table Wine Consumption (Million Cases), 2005-2008 Figure 5-12: US - Dessert Wine Sales (Million Gallons), 2004-2008 Figure 5-13: US - Forecast for Dessert Wine Sales (Million Gallons), 2009-2012 Figure 5-14: US - Champagne/Sparkling Wine Sales (Million Gallons), 2004-2008 Figure 5-15: US - Forecast for Champagne/Sparkling Wine Sales (Million Gallons), 2009-2012 Figure 5-16: US - Core Wine Consumption by Color Mix (%), 2008 Figure 5-17: US - Marginal Wine Consumption by Color Mix (%), 2008 Figure 5-18: US - Red Table Wine Sales (Million Gallons), 2007 & 2008 Figure 5-19: US - White Table Wine Sales (Million Gallons), 2007 & 2008 Figure 5-20: US - Blush Table Wine Sales (Million Gallons), 2007 & 2008 Figure 5-21: California - Number of Wineries (2005-2008) Figure 5-22: California - Wine Production (Million Gallons), 2004-2008 Figure 5-23: Washington - Number of Wineries (2005-2008) Figure 5-24: Washington - Total Grape Wine Production (Tons), 2005-2008 Figure 5-25: Washington - Grape Wine Production by Color (%), 2008 Figure 5-26: Oregon - Number of Wineries (2005-2008) Figure 5-27: Oregon - Grape Wine Production (Tons), 2006-2008 Figure 5-28: Oregon - Total Wine Sales (Cases), 2005-2008 Figure 5-29: New York - Number of Wineries (2005-2008) Figure 5-30: US - Total wine Imports (Billion US$), 2005-2008 Figure 5-31: US - Imported and Domestic Wine Consumption by Generation (%), 2008 Figure 5-32: US - Imported and Domestic Wine Consumption by Segment (%), 2008 Figure 5-33: US - Wine Exports (Million US$), 2005-2008 Figure 5-34: US - Wine Exports (Million Gallons), 2005-2008 Figure 5-35: US - Share of Export in Wine Production (2005-2008) Figure 5-36: US - Wine Exports by Country (%), 2008 Figure 5-37: US - Wine Exports by Product (Million Hectoliter), 2006-2008 Figure 5-38: US - Wine Distribution Networks (%), 2006 Figure 6-1: US - Wine Purchasing Frequency of Core Drinkers by Price Point (2007) Figure 6-2: US - Wine Purchasing Frequency of Marginal Drinkers by Price Point (2007) Figure 6-3: US - Wine Industry Revenue by Price Category (%) 1995 & 2006 Figure 6-4: US - Key Premium Wine Consumers by Segment (%) Figure 6-5: US - Adult Wine Consumer Segment (%), 2008 Figure 6-6: US - Core Wine Consumers by Generation (%), 2007 Figure 6-7: US - Marginal Wine Consumers by Generation (%), 2007 Figure 6-8: US - Number of Glasses per Occasion by Generation (2008) Figure 6-9: US - Male and Female Wine Drinkers by Generation (%), 2008 Figure 7-1: US - Online Wine Purchases by Segment (%), 2005 & 2008

Companies Mentioned

- Teva Pharmaceutical Industries Limited - Watson Pharmaceuticals, Inc. - Mylan Laboratories Inc. - Sandoz Inc. - Pfizer